The interleukin-3 receptor alpha chain (IL-3Rα), named as CD123, is widely overexpressed in various hematological malignancies, especially in the leukemic stem cells and more differentiated leukemic blasts, which makes CD123 a promising therapeutic target. The gene discussed is IL3RA; the disease is hematologic disorder.